BILLERICA, Mass., May 4, 2018 /PRNewswire/ -- Bruker Corporation (NASDAQ: BRKR) announced today it will participate in the 43rd Annual Deutsche Bank Health Care Conference in Boston. Frank Laukien, President and CEO, will present on behalf of the company on Tuesday, May 8th, 2018 at 10:00 AM Eastern Time.
A live audio webcast of the presentation will be available on the Investors section of the Company's website at https://ir.bruker.com. A replay of the presentation will be posted on the Bruker Corporation Investor Relations website after the event and will be available for 30 days following the presentation.
About Bruker Corporation
For more than 55 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology. For more information, please visit: www.bruker.com.
Head of Investor Relations
T: +1 (978) 663 – 3660, ext. 1479
SOURCE Bruker Corporation